Solaris is currently in the development of several generic dermatology products & is committed to establish itself as a pacesetter in dermatology pharmaceuticals. We are looking for a F/T R&D Scientist with Tech Transfer experience. If you're interested or know someone, contact me at 908-800-0323 or rmarrero@solaris-pharma.com
Solaris Pharma Corporation’s Post
More Relevant Posts
-
A list of Pharmaceutical Eye Drops and Dermatology medicines in which WX Pharma Deals. #PharmaSuppliers #MedicalWholesalers #SurgicalExports #HealthcareProducts #PharmaExports #MedicalSupplyChain #SurgicalInnovation #HealthcareDistribution #PharmaManufacturing #MedicalDevices #SurgicalSolutions #GlobalHealthcare #PharmaIndustry #MedicalExporters #SurgicalInstruments #medicineindia
To view or add a comment, sign in
-
-
Did you know that as part of our comprehensive service portfolio, we continuously offer clinical/regulatory dermatology consulting services? 📚 Whether you are aiming to 𝗽𝗲𝗻𝗲𝘁𝗿𝗮𝘁𝗲 𝘁𝗵𝗲 𝗨𝗦 𝗼𝗿 𝗘𝗨 𝗺𝗮𝗿𝗸𝗲𝘁𝘀, require 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝘀𝘂𝗽𝗽𝗼𝗿𝘁, or simply need clinical/regulatory guidance, our expert teams will assist you through these critical tasks, helping to guide you through the regulatory process to position your product for success! 🚀 #DermatologyCRO #ClinicalRegulatoryConsulting #RegulatoryAffairs __ Saviez-vous qu'Innovaderm offrait des services de consultation clinique/réglementaire ? 📚 Bénéficiez de l’expertise d’Innovaderm et de Regdev ! 🚀 RegDev, Inc. https://shorturl.at/bnP12
To view or add a comment, sign in
-
Great article in the Financial Times: clearly a must read to learn more about Alys Pharmaceuticals.
Special thanks to Clive Cookson and the Financial Times for covering the launch of Alys Pharmaceuticals. Chairman Francesco De Rubertis and COO Thibaud Portal spoke to Clive on the story behind Alys, from the origins of the six asset-centric subsidiary companies, to the $100M in seed financing from Medicxi and the wealth of experience and expertise among the esteemed group of co-founders and scientific leadership. With a vision to transform the treatment paradigm for several dermatology indications, Alys boasts a robust pipeline of innovative programs and platforms. Read the article here: https://lnkd.in/eawCmeue For more information on the Alys story, visit our website: alyspharma.com
New biotech aims to alleviate suffering caused by skin diseases
ft.com
To view or add a comment, sign in
-
💊 In a market where more than 370 pharmaceutical companies operate, we continue to strengthen our presence in the areas that represent us - dermatology and anti-infectives for systemic use, and to come up with new therapeutic solutions to meet the expectations of patients and healthcare professionals. • • • More details about the evolution in the internal market in 2023 can be found in the infographics below. 👇 #pharmaindustry #businessgrowth #sustainablebusiness
To view or add a comment, sign in
-
Evidence from developed countries has shown that pharmacists are often used as a source of advice on skin problems. Is this the same case in Kenya??? Pharmacists play a crucial role in skincare by providing advice on over-the-counter products, explaining proper usage, and suggesting suitable options for skin conditions. They also assist in managing medication side effects which manifest on the skin. In many cases dermatological conditions are managed with many drugs and the pharmacists will look out for compatibility of all the prescribed medications. Some skin conditions require long term self management and the pharmacist being accessible to the patient will conveniently provide the needed professional advice. Collaboration between pharmacists and Dermatologists enhances patient care. So as #pharmacists it is important that we understand the skin, the common pathologies that affect the skin and different ways to manage these conditions. With this knowledge, the pharmacist will be equipped to provide skincare advice to patients and the general public. L’Oreal Dermatological Beauty Division of L'Oréal is committed to partnering with Healthcare Professionals to meet their expectations and those of their patients. I will be speaking at the The Pharmaceutical Society of Kenya (PSK) CPD accredited CME on The Role of Pharmacists is Dermatological care on 30th November 2023. See poster and registration link below. https://lnkd.in/dymwmPZu #skincare #dermocosmetics #lorealdermatologicalbeauty
The Pharmaceutical Society of Kenya (PSK) in partnership with L'Oréal Dermatology invites you to an webinar on: 📋 Pharmacists in Dermatological Care 🗓 Thursday, 30th November 2023 ⏰ 7:00 pm EAT Register here in advance ; 🔗⤵⤵ https://lnkd.in/dDQJ54jt Evalyn Allela Dr. Murage Karimi Dr. M. S. Louis Michael Mungoma Dr. Joseph Murithi Kathare Dr. Angeline Achoka Daniella Munene Dr. Hezron Munyakin Myles G. Amos Manyange Dr. Ivy Ratemo
To view or add a comment, sign in
-
-
Yesterday I presented our poster on new insights to complex excipients and the impact on formulation design at the Dermatology Drug Development Summit in Boston. I enjoyed the really good discussions we had on this topic! Over the last years, at RaDes GmbH we developed innovative and very powerful analytical methods for complex surfactants (they almost all are complex!) and lipids. These methods allow a better understanding of the true composition of these excipients which helps to better understand how they impact on formulation design at the level of the different components they contain. In addition, they allow to understand batch-to-batch and supplier-to-supplier variability for critical materials. #excipients #analytics #formulationdevelopment
To view or add a comment, sign in
-
-
Managing Director at Monasterium Laboratory Skin & Hair Research Solutions GmbH - A QIMA Life Sciences Company
Don't miss our live 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝗗𝗲𝗿𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 & 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁! 👉 REGISTER HERE: https://lnkd.in/eR_P94BN #drugdevelopment #dermatology #pharma #webinar
[WEBINAR] 📅 We are excited to invite you to our upcoming free #LiveWebinar on July 11th at 4 p.m. In this webinar, our experts will lead you through the #DrugDiscovery and #Development process, showcasing insightful dermatology case studies where we have helped clients achieve their research goals. 💡 Discover how our established and custom-developed models and tests contributed to the success of other projects - and see how they can benefit yours next! 👩🔬 If you work in the field of #Dermatology, or are simply interested in learning more about it, this is an opportunity you won't want to miss! This webinar will be presented by Séverine Thibaut de Ménonville 🧪 🧬 from QIMA Life Sciences, Marta Bertolini, PhD from Monasterium Laboratory Skin & Hair Research Solutions GmbH, and Jean-Michel Delaval from Newtone Technologies. 🖱 CLICK HERE TO REGISTER: https://lnkd.in/eR_P94BN #Healthcare #Pharma #Pharmaceutical #Research #ClinicalTrials
To view or add a comment, sign in
-
-
Where will emerging #biologics fit into the #atopicdermatitis algorithm? As the American Academy of Dermatology meeting approaches, FirstWord will host a call with a KOL to discuss #emergingtrends in the treatment of atopic dermatitis. Learn more here: https://lnkd.in/dUKJmMYQ #clinicalresearch #dermatitis #pharmaceuticals
KOL Views Preview: Where will emerging biologics fit into the atopic dermatitis algorithm?
ml.firstwordpharma.com
To view or add a comment, sign in
-
With more than 20 completed dermatology studies, AutoCruitment is one of the leaders in patient recruitment for dermatological conditions. #dermatology #clinicaltrials #clinicalresearch #patientrecruitment #biopharmaceutical #lifesciences #biotech #pharmaceutical
To view or add a comment, sign in
-
-
BioPharma Practice Leader | Market Access | BD, Licensing & Partnerships | Commercial Strategy | Research & Analysis | Strategic Intelligence |
Vitiligo is a large untapped market for Biopharma Ø Vitiligo, an autoimmune dermatology condition is associated with loss of pigmentation due to the progressive destruction of melanocytes, the skin cells that produce melanin, responsible for skin color Ø Vitiligo affects ~2% of the global population. Researchers estimate ~3 million in the USA to have vitiligo, with 40 percent of adults going undiagnosed. Vitiligo is highly underreported and therefore the addressable population could be a lot larger Ø Facial depigmentation is by far the most important aspect of vitiligo with hand involvement the next most important area of concern Ø Although not curative, there are several options available to clear existing vitiligo patches and prevent them from growing. Among them include topical corticosteroids, phototherapy, and Surgical treatment Ø In July 2022 , the FDA approved Incyte’s OPZELURA (ruxolitinib) cream, the first pharmaceutical treatment option ever for the most common form of vitiligo. The FDA had previously approved ruxolitinib, a JAK inhibitor for mild to moderate atopic dermatitis (eczema), in the fall of 2021 #marketanalysis #marketresearch #competitiveintelligence #vitiligo #dermatology #skinhealth #eosintelligence #perspectives #pharmaceuticals #biotech #consulting #marketing #mangement #leadership #healthcare #insights #autoimmunediseases Incyte Novartis Almirall ------------------------------------------------------------------------------------ Ready to leverage the power of intelligence to drive the rapidly developing "Dermatology" product development and commercialization strategy? At EOS Intelligence, we offer competitive intelligence monitoring services in key therapeutic areas with earnings call analyses, conference highlights, pipeline asset review, and strategic recommendation to make you stay ahead of the curve. Let us know your perspectives & challenges and we will get you covered. Write us at bhabesh.panigrahi@eos-intelligence.com
To view or add a comment, sign in